Effects of Smoked Marijuana on Neuropathic Pain
NCT00254761 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 28
Last updated 2008-02-28
Summary
To determine if smoking marijuana will reduce neuropathic pain without causing too much drowsiness or feeling "too dopey".
Conditions
- Neuropathic Pain
Interventions
- DRUG
Sponsors & Collaborators
-
Center for Medicinal Cannabis Research
lead OTHER
Principal Investigators
-
Barth L Wilsey, M.D. · University of California, Davis
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-11-30
- Primary Completion
- 2006-02-28
- Completion
- 2006-02-28
Countries
- United States
Study Locations
More Related Trials
-
A Study of Cannabis Based Medicine Extracts and Placebo in Patients With Pain Due to Spinal Cord Injury
NCT01606202 ·Status: COMPLETED ·Phase: PHASE3
-
Medicinal Cannabis for Painful HIV Neuropathy
NCT00255580 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Proof of Concept Trial of Cannabis Derivatives in Neuropathic Pain
NCT05351801 ·Status: RECRUITING ·Phase: PHASE2
-
Pain Response to Cannabidiol in Induced Acute Nociceptive Pain, Allodynia and Hyperalgesia By Using a Model Mimicking Acute Pain in Healthy Adults
NCT03985995 ·Status: COMPLETED ·Phase: NA
-
The Effects and Mechanisms of a High CBD Cannabis Extract (BRC-002) for the Treatment of Pain and Health in Complex Regional Pain Syndrome
NCT06393101 ·Status: RECRUITING ·Phase: PHASE1
-
CBD for Chronic Radicular Pain on Chronic Opioid Therapy (COT)
NCT04760613 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study to Compare Sublingual Cannabis Based Medicine Extracts With Placebo to Treat Brachial Plexus Injury Pain
NCT01606189 ·Status: COMPLETED ·Phase: PHASE3
-
Study of CBME in the Relief of Painful Diabetic Neuropathy
NCT00238550 ·Status: COMPLETED ·Phase: PHASE2
-
MIVetsCan: Cannabidiol (CBD)-Care Trial
NCT06213233 ·Status: RECRUITING ·Phase: PHASE2
-
Placebo In Chronic Back Pain - Double-Blind Randomized Control Trial
NCT02013427 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Sativex® for Relief of Peripheral Neuropathic Pain Associated With Allodynia.
NCT00711880 ·Status: COMPLETED ·Phase: PHASE3
-
Intrathecal Therapy for Chronic Non-Cancer Pain: An Analysis of Its Efficacy
NCT01564069 ·Status: COMPLETED
-
Ketamine's Efficiency in the Treatment of Chronic Pain: Kynurenin Pathway
NCT03513822 ·Status: UNKNOWN ·Phase: PHASE3
-
Effects of Intravenous GSK3858279 on a Battery of Evoked Pain Tests in Healthy Volunteers
NCT04114656 ·Status: TERMINATED ·Phase: PHASE1
-
Randomized Controlled Study of the Efficacy of Hypnosis Versus Relaxation and Control in Neuropathic Pain
NCT02256371 ·Status: COMPLETED ·Phase: NA
-
Effect of Cannabinoids on Pain in Fabry Disease Patients
NCT04820361 ·Status: UNKNOWN ·Phase: NA
-
CANPAIN Feasibility Study Pragmatic Real World Trial Investigating CBMP in Chronic Pain Patients
NCT05288010 ·Status: UNKNOWN ·Phase: PHASE3
-
A Study Intended to Evaluate Safety, Tolerability and Pharmacokinetics (PK) Parameters of BL-1021
NCT01121380 ·Status: TERMINATED ·Phase: PHASE1
-
Psychotherapy for Ketamine's Enhanced Durability in Chronic Neuropathic Pain: A Randomized Controlled Pilot Trial
NCT05639322 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of Cunermuspir on Energy, Strength, and Fatigue in Patients With Nerve or Muscle Pain
NCT04737278 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
MC5-A Scrambler Therapy in Reducing Peripheral Neuropathy Caused by Chemotherapy
NCT01290224 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Central Neuropathy of Any Genesis
NCT06071949 ·Status: UNKNOWN ·Phase: PHASE3
-
Dose Response and Efficacy of GW842166 in Pain
NCT00554762 ·Status: WITHDRAWN ·Phase: PHASE1
-
A Study of Sativex® for Pain Relief of Peripheral Neuropathic Pain, Associated With Allodynia
NCT00710554 ·Status: COMPLETED ·Phase: PHASE3
-
Nabilone and THC/CBD for the Treatment of FBSS Refractory Pain
NCT03210766 ·Status: COMPLETED